Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China

by Shukui Qin, Eliza Kruger, Seng Chuen Tan, Shuqun Cheng, Nanya Wang, Jun Liang
Published 2018-08-01

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carc...

by Jie Shi, Juxian Sun, Chang Liu, Zongtao Chai, Nanya Wang, Hui Zhang, Shuqun Cheng
Published 2019-04-01

Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer

by Lijuan Ding, Feng Wei, Nanya Wang, Yue Sun, Qiang Wang, Xia Fan, Ling Qi, Shudong Wang
Published 2021-01-01

Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients

by Lei Qian, Nanya Wang, Huimin Tian, Haofan Jin, Hengjun Zhao, Chao Niu, Hua He, Tingwen Ge, Wei Han, Jifan Hu, Dan Li, Fujun Han, Jianting Xu, Xiao Ding, Jingtao Chen, Wei Li, Jiuwei Cui
Published 2016-01-01